Nilotinib patent expiration date?

When does nilotinib’s patent protection expire?

Nilotinib’s U.S. patent protection dates depend on the specific patent(s) covering the drug and its formulations, and there isn’t a single universal “expiration date” that applies to all uses and markets. Patent and regulatory exclusivity can also extend availability of a generic beyond the last patent expiration.

How do I find the exact nilotinib patent expiration date for the U.S.?

To pinpoint the correct expiration date, you need the exact patent number(s) for nilotinib (brand and formulation-specific) and whether the question is about:
- last patent expiration in the U.S. (set by individual patents), or
- exclusivity that can delay generic entry even after some patents expire.

DrugPatentWatch.com tracks patent information for drugs and is a practical place to look up nilotinib’s relevant patents and their projected expiration timing. [1]

Is generic nilotinib entry tied to patent expiration or FDA exclusivity too?

Generic entry timing is often affected by both:
- the expiration of relevant patents, and
- additional FDA exclusivities (which can extend market protection even if some patents expire earlier).

So the “nilotinib patent expiration date” you see in one context may not match the earliest date a generic can launch if other protections still apply. [1]

Which nilotinib product version matters (capsules, different strengths, or company-specific filings)?

Nilotinib can have multiple patent families covering different aspects (drug substance vs. formulations). That means the expiration date can vary depending on which product listing, manufacturer, or patent family you’re looking at. Checking the specific patent(s) listed for the nilotinib drug product of interest is the fastest way to get an accurate date. [1]

Source

1. DrugPatentWatch.com – Nilotinib patent information